INFLAMMATORY BOWEL DISEASE MONITOR.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 85
- Publication type:
- Article
Works matching IS 14667401 AND DT 2012 AND VI 13 AND IP 2
Results: 27
1
2
EVENTS 2013.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 84
- Publication type:
- Article
3
Report from the Digestive Disorders Federation Conference.
- Published in:
- 2012
- By:
- Publication type:
- Proceeding
4
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 69
- Publication type:
- Article
5
Challenges to the design, execution, and analysis of randomized controlled trials for inflammatory bowel disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 78
- Publication type:
- Article
6
Andrographis paniculata extract (HMPL-004) for active ulcerative colitis.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 70
- Publication type:
- Article
7
Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ Registry.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 76
- Publication type:
- Article
8
Risk of ischaemic heart disease in patients with inflammatory bowel disease: a nationwide Danish cohort study.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 77
- Publication type:
- Article
9
5-aminosalicylic acid is not protective against colorectal cancer in inflammatory bowel disease: a meta-analysis of non-referral populations.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 76
- Publication type:
- Article
10
Association between anti-TNF-α therapy and all-cause mortality.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 75
- Publication type:
- Article
11
A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 75
- Publication type:
- Article
12
Effect of communicating DNA based risk assessments for Crohn's disease on smoking cessation: randomised controlled trial.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 74
- Publication type:
- Article
13
Lymphocytic oesophagitis: clinicopathological aspects of an emerging condition.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 73
- Publication type:
- Article
14
Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 73
- Publication type:
- Article
15
Increased small intestinal permeability in ulcerative colitis: rather genetic than environmental and a risk factor for extensive disease?
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 72
- Publication type:
- Article
16
Influence of polymorphisms and TNF and IL1β serum concentration on the infliximab response in Crohn's disease and ulcerative colitis.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 72
- Publication type:
- Article
17
IL-1β mediates chronic intestinal inflammation by promoting the accumulation of IL-17A secreting innate lymphoid cells and CD4<sup>+</sup> Th17 cells.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 71
- Publication type:
- Article
18
Diagnostic accuracy of magnetic resonance colonography for the evaluation of disease activity and severity in ulcerative colitis: a prospective study.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 71
- Publication type:
- Article
19
Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitis.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 70
- Publication type:
- Article
20
Nutritional therapy versus 6-mercaptopurine as maintenance therapy in patients with Crohn's disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 68
- Publication type:
- Article
21
Once-daily budesonide MMX® extended-release tablets induce remission in patients with mild to moderate ulcerative colitis: results from the CORE I study.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 68
- Publication type:
- Article
22
A randomised, double-blind, sham-controlled study of granulocyte/monocyte apheresis for moderate to severe Crohn's disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 67
- Publication type:
- Article
23
Vedolizumab for the treatment of active ulcerative colitis: a randomized controlled Phase 2 dose-ranging study.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 67
- Publication type:
- Article
24
Anti-tumour necrosis factor treatment of inflammatory bowel disease in liver transplant recipients.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 66
- Publication type:
- Article
25
IBD and Venous Thromboembolism: A Review.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 58
- By:
- Publication type:
- Article
26
Bone Protection Measures in Children and Adolescents with IBD.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 51
- By:
- Publication type:
- Article
27
Laparoscopic Versus Open Surgery in Crohn's Disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2012, v. 13, n. 2, p. 43
- By:
- Publication type:
- Article